If you have an autoimmune condition like rheumatoid arthritis or lupus, your HRV is probably lower than it should be. This isn't just a curiosity - autonomic dysfunction in autoimmune disease predicts cardiovascular risk, correlates with disease activity, and may even precede symptom onset.
The good news: treating the underlying inflammation helps restore HRV, and vagal interventions show promise as adjunctive therapy.
The Inflammation-HRV Connection
A 2025 cross-sectional study of 314 rheumatoid arthritis patients in India found significant correlations between HRV and disease markers[1]:
DAS-28 (disease activity): Lower SD rate BPM correlated with higher disease activity (r = -0.171, p < 0.01)
HAQ (functional disability): Lower SDRR correlated with worse function (r = -0.135, p < 0.05)
ESR (inflammation): Lower SDRR and LF power correlated with higher ESR (r = -0.153 and -0.190, p < 0.01)
Linear regression confirmed: "SD rate BPM had a significant negative association with HAQ Score (B = -0.033, p = 0.015)."
Translation: Higher inflammation and worse disease activity = lower HRV.
How Common Is Autonomic Dysfunction?
Very common. Earlier investigations revealed 61-75% of RA patients exhibit cardiovascular autonomic dysfunction, marked by reduced parasympathetic response and augmented sympathetic nervous system activity[2].
Systemic lupus erythematosus (SLE) shows similar patterns. One study found impaired HRV, particularly the LF/HF ratio, is associated with lupus disease activity and cytokines related to IFN type II and TNF pathways[3].
The Bidirectional Relationship
Here's what makes this interesting: autonomic dysfunction may precede autoimmune disease, not just result from it.
A prospective cohort study found that autonomic dysfunction predated the development of rheumatoid arthritis[4]. This suggests the relationship between the nervous system and immune system is bidirectional - the vagus nerve doesn't just respond to inflammation, it actively regulates it.
This is the cholinergic anti-inflammatory pathway: vagal signals reduce pro-inflammatory cytokine production through α7-nicotinic cholinergic receptors[5].
What Happens When You Treat the Inflammation?
Anti-inflammatory treatment improves HRV. Specifically:
Anticytokine therapy with synthetic DMARDs and biologic DMARDs improves cardiovascular autonomic neuropathy in RA
More potent treatment with biologic DMARDs improves parasympathetic and sympathetic autonomic dysfunction to a greater extent
IL-6 blockade with tocilizumab also improves autonomic neuropathy
This confirms the inflammation-HRV connection isn't just correlational - reducing inflammation causally improves autonomic function[6].
Can Vagal Interventions Help?
The bidirectional relationship opens up an interesting therapeutic avenue: what if stimulating the vagus nerve could reduce autoimmune inflammation?
A 2025 systematic review examined vagus nerve stimulation across 8 autoimmune conditions (Crohn's disease, inflammatory bowel disease, rheumatoid arthritis, SLE, systemic sclerosis, MS, Type 1 diabetes, and Sjögren's syndrome)[5].
Strongest evidence:
Crohn's disease: Five patients achieved clinical remission, six achieved endoscopic remission after one year
Rheumatoid arthritis: Three studies using DAS28-CRP scores showed "significant reductions in disease activity"
TNF-α production was significantly inhibited in RA patients receiving chronic VNS.
Deep breathing also works:
A study comparing transcutaneous auricular VNS (taVNS) and deep breathing in RA and SLE patients found:
After deep breathing: HRV parameters increased 17-31%
After taVNS: HRV parameters increased 18-25%
No significant difference between the two interventions[7]
In healthy participants, deep breathing increased HRV more (21-46%) than taVNS (16%). But for autoimmune patients, both interventions produced similar improvements.
What This Means for You
If you have an autoimmune condition:
Know that lower HRV is common and not just "stress" - it reflects inflammatory burden
Effective disease treatment should improve your HRV over time
Track HRV changes with treatment modifications
Consider vagal-boosting interventions (resonance breathing, HRV biofeedback) as adjunctive support
HRV tracking utility:
Baseline HRV before treatment starts provides comparison
Rising HRV during treatment suggests better inflammatory control
Persistently low HRV despite treatment may indicate incomplete disease control
What won't help:
Expecting HRV to normalize without treating underlying disease
Using HRV alone to guide treatment decisions (work with your rheumatologist)
The Takeaway
Autoimmune disease and low HRV go together through the cholinergic anti-inflammatory pathway. Inflammation suppresses vagal tone, and vagal tone suppresses inflammation. Treating the underlying disease improves HRV, and vagal interventions may help reduce disease activity - though they're adjunctive to standard treatment, not replacements.
For those with autoimmune conditions tracking HRV: context matters. Your baseline will likely be lower than healthy controls, and improvements should be measured against your own starting point, not population averages.